Our Team

Rossitsa Vrabevska, Chief Medical Officer, MD, graduated from Medical University in Plovdiv, Bulgaria. After completing graduate courses (MSC) in Pharmacology at Massachusetts College of Pharmacy, Boston, USA, she gained pre-clinical and bioanalytical experience in the US (incl. Channing Laboratory, Harvard Medical School) and Japan. Joining Comac Medical in 2005, Dr. Vrabevska worked as Clinical Research Associate, Clinical Trial Manager, Director of Early Phase studies department in more than 100 clinical trials in Phase I/IIA and BA/BE. As a Chief Medical Officer since 2017, her responsibilities included oversight of the clinical development programs in Early Phase Trials, Scientific Advisory Group, Project Management and Quality.

Vladimir Goranov, M.Sc., CO-CEO, has strong experience in accounting and finance in manufacturing and trading companies where he has held executive positions and has been in charge of financial and reporting departments. Currently he manages the Business Development functional group within Comac Medical and oversees activities related to the preparation of Comac Medical bids and proposals.